Cognios Capital LLC acquired a new stake in Cigna Corp (NYSE:CI) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 1,775 shares of the health services provider’s stock, valued at approximately $269,000.
Other large investors have also made changes to their positions in the company. Captrust Financial Advisors grew its stake in shares of Cigna by 1.4% during the 2nd quarter. Captrust Financial Advisors now owns 4,288 shares of the health services provider’s stock worth $676,000 after acquiring an additional 61 shares during the period. Prime Capital Investment Advisors LLC grew its stake in shares of Cigna by 32.5% during the 2nd quarter. Prime Capital Investment Advisors LLC now owns 257 shares of the health services provider’s stock worth $40,000 after acquiring an additional 63 shares during the period. Pinnacle Associates Ltd. grew its stake in shares of Cigna by 2.2% during the 2nd quarter. Pinnacle Associates Ltd. now owns 3,145 shares of the health services provider’s stock worth $495,000 after acquiring an additional 67 shares during the period. Private Trust Co. NA grew its stake in shares of Cigna by 2.9% during the 3rd quarter. Private Trust Co. NA now owns 2,377 shares of the health services provider’s stock worth $360,000 after acquiring an additional 67 shares during the period. Finally, Signaturefd LLC grew its stake in shares of Cigna by 2.6% during the 2nd quarter. Signaturefd LLC now owns 2,657 shares of the health services provider’s stock worth $419,000 after acquiring an additional 68 shares during the period. Hedge funds and other institutional investors own 87.45% of the company’s stock.
In other Cigna news, CEO David Cordani purchased 32,509 shares of the stock in a transaction on Monday, September 9th. The shares were purchased at an average price of $155.17 per share, with a total value of $5,044,421.53. Company insiders own 0.80% of the company’s stock.
Shares of NYSE CI opened at $172.89 on Thursday. Cigna Corp has a 52 week low of $141.95 and a 52 week high of $226.60. The business has a 50-day simple moving average of $157.19 and a two-hundred day simple moving average of $159.33. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.84. The company has a market cap of $65.29 billion, a P/E ratio of 12.16, a P/E/G ratio of 0.87 and a beta of 0.71.
Cigna (NYSE:CI) last released its quarterly earnings results on Thursday, August 1st. The health services provider reported $4.30 earnings per share for the quarter, beating the consensus estimate of $3.74 by $0.56. Cigna had a return on equity of 13.24% and a net margin of 3.60%. The firm had revenue of $34.38 billion for the quarter, compared to analysts’ expectations of $33.27 billion. During the same quarter last year, the firm posted $3.89 EPS. The company’s revenue was up 198.9% compared to the same quarter last year. Equities research analysts anticipate that Cigna Corp will post 16.77 EPS for the current year.
Cigna Company Profile
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Featured Story: Analyzing a company’s cash flow statement
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.